## Abstract The tumor suppressor gene __maspin__ has been reported to inhibit the invasiveness and motility of breast cancer cells. It has been reported that maspin is expressed in normal human mammary epithelial cells but is downregulated during cancer progression, and that p53 could induce maspin
Altered expression of p120catenin predicts poor outcome in invasive breast cancer
✍ Scribed by K. Talvinen; J. Tuikkala; M. Nykänen; A. Nieminen; J. Anttinen; O. S. Nevalainen; S. Hurme; T. Kuopio; P. Kronqvist
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 420 KB
- Volume
- 136
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Synuclein γ (SNCG), previously identified as a breast cancer‐specific gene (BCSG1), is highly expressed in breast carcinomas but not in normal epithelium. SNCG regulates many pathways in growth and progression of breast cancer. To determine if SNCG is a biomarker for clinical prognosis
## Abstract The prognostic significance of __BRCA2__ mRNA levels in tumor tissues was studied in sporadic breast cancer patients. __BRCA2__ mRNA levels were determined by real‐time PCR. Histologic grade III tumors showed significantly (__p__ = 0.001) higher __BRCA2__ mRNA levels (0.828 ± 0.102 __BR
## Abstract HDPR1 (human homologue of Dapper) is considered as a Dishevelled (DVL) antagonist in WNT signaling. We recently reported that DVL was associated with cytoplasmic accumulation of β‐catenin in nonsmall cell lung cancer (NSCLC). Whether cytoplasmic accumulation of β‐catenin is correlated w